Skip to content

Drug interactions

Imatinib + Zanubrutinib

Severity: Moderate

Imatinib and Zanubrutinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib may increase zanubrutinib exposure by inhibiting CYP3A4. This may increase bleeding, cytopenias and infection risk.

What this interaction means in plain words

Imatinib and Zanubrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Zanubrutinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Imatinib inhibits CYP3A4-mediated metabolism of zanubrutinib.

What to do

Reduce zanubrutinib to the labeled lower dose while on the moderate CYP3A inhibitor. Monitor blood counts and bleeding.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Zanubrutinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Zanubrutinib?

MediHelp rates the interaction as moderate. Imatinib and Zanubrutinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib may increase zanubrutinib exposure by inhibiting CYP3A4. This may increase bleeding, cytopenias and infection risk.

How serious is the interaction between Imatinib and Zanubrutinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce zanubrutinib to the labeled lower dose while on the moderate CYP3A inhibitor. Monitor blood counts and bleeding.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in